Biotech

Category / Pharmaceuticals & Biotech / Biotech

Threshold Pharmaceuticals Announces Initiation of TH-302 Phase 3 MAESTRO Study in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma

SOUTH SAN FRANCISCO, CA: Threshold Earns a $30 Million Milestone Payment From Merck KGaA ...

Helix Announces Shareholder Approval for the Sale of Its Rivex Pharma Division to Pharmascience and Other Results of Its Annual General and Special Meeting

AURORA, ON: ...

Regen BioPharma Peer-Reviewed Publication Provides Preclinical Support for HemaXellerate(TM) Bone Marrow Failure Product

SAN DIEGO, CA: Bio-Matrix Subsidiary's Publication Is Scientific Basis for IND Submission Currently in Preparation ...

Crown Marketing Reviews Licensing Technology for Nutraceutical and Supplement Market

CHAPEL HILL, NC: ...

Prima BioMed to Host Investor Days in Australia

SYDNEY, AUSTRALIA: ...

Immunovative, Inc. Discovers Material Information in Connection With Its Lawsuit Against Immunovative Therapies, Ltd. ("ITL")

NEW YORK, NY: ...

Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx(TM) Clinical Studies; Precision Therapeutics Prepares for Commercial Launch

PITTSBURGH, PENNSYLVANIA and VANCOUVER, BRITISH COLUMBIA: ...

Crown Files to Preserve Patent Rights in India

CHAPEL HILL, NC: ...

Cytovance(R) Biologics Welcomes Maria Lopez as Vice President of Quality

OKLAHOMA CITY, OK: ...

Culminatum Innovation and Diaceutics Collaborate to Provide Expert Training to Leading Finnish Researchers on Commercializing Biomarkers for Personalized Medicine

DUBLIN, IRELAND: ...

Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17E

TORONTO, ONTARIO: ...

Edge Therapeutics Appoints Dr. Sol Barer and Isaac Blech as Chairman and Vice Chairman of Its Board of Directors

NEW PROVIDENCE, NJ: ...

Alliance of Translational Research Centres Established to Accelerate Global Drug Development

LONDON, UNITED KINGDOM and VANCOUVER, BRITISH COLUMBIA: ...

Theratechnologies Inc.: FDA Approves Alternative Storage Conditions for EGRIFTA(TM)

MONTREAL, QUEBEC: ...

Octapharma Receives US Regulatory Approval for Octaplas(R)

LAVAL, QUEBEC: ...

Crown Marketing's Japanese Patent Approved and Registered

CHAPEL HILL, NC: ...

Ingen Ramps Up Its Manufacturing for Its Initial Approximate $3 Million in Purchase Orders

RIVERSIDE, CA: ...

Crown Technology May Allow Multi-Year Patent Extension of Blockbuster Drugs

CHAPEL HILL, NC: ...

Paladin Labs Signs Agreement for Novel Biologic to Treat Neuroblastoma

MONTREAL, CANADA: ...

Sunshine Heart Enters Into a $25 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Page 157 von 247: 1 « .. 156 157 158 159 160 161 162 163 164 165 .. » 247

All members:	10 566
Register today:	1
Register yesterday:	0
Members online:	0
Guests online:	81

Biotech

Category / Pharmaceuticals & Biotech / Biotech

Threshold Pharmaceuticals Announces Initiation of TH-302 Phase 3 MAESTRO Study in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Helix Announces Shareholder Approval for the Sale of Its Rivex Pharma Division to Pharmascience and Other Results of Its Annual General and Special Meeting

Regen BioPharma Peer-Reviewed Publication Provides Preclinical Support for HemaXellerate(TM) Bone Marrow Failure Product

Crown Marketing Reviews Licensing Technology for Nutraceutical and Supplement Market

Prima BioMed to Host Investor Days in Australia

Immunovative, Inc. Discovers Material Information in Connection With Its Lawsuit Against Immunovative Therapies, Ltd. ("ITL")

Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx(TM) Clinical Studies; Precision Therapeutics Prepares for Commercial Launch

Crown Files to Preserve Patent Rights in India

Cytovance(R) Biologics Welcomes Maria Lopez as Vice President of Quality

Culminatum Innovation and Diaceutics Collaborate to Provide Expert Training to Leading Finnish Researchers on Commercializing Biomarkers for Personalized Medicine

Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17E

Edge Therapeutics Appoints Dr. Sol Barer and Isaac Blech as Chairman and Vice Chairman of Its Board of Directors

Alliance of Translational Research Centres Established to Accelerate Global Drug Development

Theratechnologies Inc.: FDA Approves Alternative Storage Conditions for EGRIFTA(TM)

Octapharma Receives US Regulatory Approval for Octaplas(R)

Crown Marketing's Japanese Patent Approved and Registered

Ingen Ramps Up Its Manufacturing for Its Initial Approximate $3 Million in Purchase Orders

Crown Technology May Allow Multi-Year Patent Extension of Blockbuster Drugs

Paladin Labs Signs Agreement for Novel Biologic to Treat Neuroblastoma

Sunshine Heart Enters Into a $25 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

Service Menu

New here

Who is online